Pharmacokinetic study of S-1.
Mende
B
B
Department of Internal Medicine, University of Essen Medical School, Essen, Germany.
Krauss
J
J
Thyssen
D
D
Kredtke
S
S
Scheulen
M E
ME
Strumberg
D
D
Hanauske
A
A
Makris
L
L
Scigalla
P
P
Urrea
P D
PD
Hilger
R A
RA
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000008:administration & dosage; D000284:Administration, Oral; D000897:Anti-Ulcer Agents / Q000008:administration & dosage; D000964:Antimetabolites, Antineoplastic / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019540:Area Under Curve; D001682:Biological Availability; D002986:Clinical Trials as Topic; D042943:Dihydrouracil Dehydrogenase (NADP) / Q000097:blood; D004338:Drug Combinations; D005215:Fasting; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000378:metabolism; D005502:Food; D005745:Gastric Acidity Determination; D006207:Half-Life; D006801:Humans; D006863:Hydrogen-Ion Concentration; D010094:Oxonic Acid / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D000077402:Pantoprazole; D011725:Pyridines / Q000378:metabolism / Q000493:pharmacokinetics / Q000627:therapeutic use; D005641:Tegafur / Q000097:blood / Q000378:metabolism / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D014227:Triazines / Q000378:metabolism; D014498:Uracil / Q000031:analogs & derivatives / Q000378:metabolism; D015091:beta-Alanine / Q000031:analogs & derivatives / Q000378:metabolism
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D000897:Anti-Ulcer Agents; D000964:Antimetabolites, Antineoplastic; D004338:Drug Combinations; D011725:Pyridines; D014227:Triazines; C007419:dihydrouracil; D015091:beta-Alanine; C079198:S 1 (combination); D005641:Tegafur; C032348:alpha-fluoro-beta-alanine; C489337:potassium oxonate; D014498:Uracil; D010094:Oxonic Acid; C019389:5-fluorodihydrouracil; D000077402:Pantoprazole; D042943:Dihydrouracil Dehydrogenase (NADP); C004632:cyanuric acid; D005472:Fluorouracil; C104201:gimeracil